JAAD international · 2024
Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Siranart Noppachai, Chumpangern Yanisa, Phutinart Somkiat, Pajareya Patavee, Worapongpaiboon Rinrada, Winson Chanissara, Thongprayoon Charat, Cheungpasitporn Wisit
Аннотация
BACKGROUND: Bullous pemphigoid (BP) is a chronic autoimmune blistering disease prevalent in the elderly, often accompanied by renal comorbidities. Immune dysregulation can lead to secondary BP and increased mortality rates in those already diagnosed.
METHODS: A literature review identified studies on the association between kidney disease and other comorbidities with BP. Pooled effect estimates were analyzed utilizing a random-effects model.
OBJECTIVE: To assess comorbidity risks with BP and determine mortality risk among BP patients with comorbidities.
RESULTS: Analysis included 45,323 BP patients from 49 studies. Kidney diseases were significantly linked to higher BP incidence (subdistribution hazard ratio 1.51, 95% CI: 1.10-2.07) and increased mortality (hazard ratio 1.62, 95% CI: 1.13-2.32). Cerebrovascular diseases, dementia, and diabetes also showed significant associations with both increased BP incidence and mortality (P < .05). However, cardiovascular diseases and malignancy were only associated with increased mortality among BP patients (P < .001) without affecting BP incidence (P = .785 and P = .792, respectively).
LIMITATION: The study comprises mostly case-control, prospective, and retrospective observational studies, alongside data heterogeneity.
CONCLUSION: This study reveals the association of several chronic conditions, including kidney diseases, with BP, contributing to elevated mortality rates. The findings emphasize the importance of management targeting both BP and associated comorbidities to improve patient outcomes.
METHODS: A literature review identified studies on the association between kidney disease and other comorbidities with BP. Pooled effect estimates were analyzed utilizing a random-effects model.
OBJECTIVE: To assess comorbidity risks with BP and determine mortality risk among BP patients with comorbidities.
RESULTS: Analysis included 45,323 BP patients from 49 studies. Kidney diseases were significantly linked to higher BP incidence (subdistribution hazard ratio 1.51, 95% CI: 1.10-2.07) and increased mortality (hazard ratio 1.62, 95% CI: 1.13-2.32). Cerebrovascular diseases, dementia, and diabetes also showed significant associations with both increased BP incidence and mortality (P < .05). However, cardiovascular diseases and malignancy were only associated with increased mortality among BP patients (P < .001) without affecting BP incidence (P = .785 and P = .792, respectively).
LIMITATION: The study comprises mostly case-control, prospective, and retrospective observational studies, alongside data heterogeneity.
CONCLUSION: This study reveals the association of several chronic conditions, including kidney diseases, with BP, contributing to elevated mortality rates. The findings emphasize the importance of management targeting both BP and associated comorbidities to improve patient outcomes.